Results 121 to 130 of about 762,436 (303)

Deprival Value and Fair Value: a Reinterpretation and a Reconciliation

, 2005
Two alternative measurement bases that have appeared in accounting standards, Deprival Value (sometimes called Value to the Business) and Fair Value, are explained and compared.
van Zijl, Tony, Whittington, Geoffrey
core  

UTJECAJ RAČUNOVODSTVA FER VRIJEDNOSTI NA KRIZU U BANKARSKOM SEKTORU EU I SAD [PDF]

, 2011
Authors who criticize fair value accounting (FVA) claim that the use of fair value accounting as a measurement attribute had essential impact on the origin, spreading and strengthening of actual global financial crisis.
Edin Kalač, Šaban Gračanin
core  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Les pratiques bancaires en matière de valorisation des instruments financiers en IFRS [PDF]

cd-romWhen financial markets are no more active, as in 2008, the question of fair value valuation techniques becomes crucial. IFRS 7 specifies a three-level hierarchy for fair value measurement disclosures: quoted market prices, valuation techniques ...
Dufour, Dominique, Heem, Gregory
core   +1 more source

Accounting for financial instruments in the banking industry: conclusions from a simulation model [PDF]

, 2003
The paper analyses the effects of three sets of accounting rules for financial instruments - Old IAS before IAS 39 became effective, Current IAS or US GAAP, and the Full Fair Value (FFV) model proposed by the Joint Working Group (JWG) - on the financial ...
Gebhardt, Günther, Reichardt, Rolf, Wittenbrink, Carsten   +2 more
core  

Feasibility studies of the time-like proton electromagnetic form factor measurements with PANDA at FAIR

, 2010
The possibility of measuring the proton electromagnetic form factors in the time-like region at FAIR with the \PANDA detector is discussed. Detailed simulations on signal efficiency for the annihilation of $\bar p +p $ into a lepton pair as well as for ...
A. A. Piskun, T. Pocheptsov, A. Bianconi, M. Bragadireanu, A. Britting, W. Eyrich, A. Ehret, H. Flemming, A. Fechtchenko, A. G. Fedunov, A. G. Olshevskiy, E. Perevalova, A. Galoyan, S. Grigoryan, A. Gerhardt, K. Goetzen, A. Gromliuk, L. Gruber, A. Hayrapetyan, M. Kesselkaul, A. Kozela, P. Kulessa, A. Lehmann, M. Pfaffinger, A. Magiera, P. Moskal, A. Mustafa, M. Pelizaeus, A. N. Skachkova, E. A. Strokovsky, A. Pyszniak, Z. Rudy, A. Samartsev, M. G. Sapozhnikov, A. Taeschner, M. Traxler, A. Vodopianov, S. A. Zaporozhets, Apostol, A., B. Kamys, S. Kistryn, B. Kopf, M. Kuhlmann, B. Krusche, M. Steinacher, B. Mindur, D. Przyborowski, B. Patel, W. Czyzycki, B. Singh, W. Erni, B. V. Batyunya, Y. Davydov, C. Hammann, B. Ketzer, C. Schnier, T. Schroeder, C. Schwarz, J. Schwiening, C. Sowa, M. Steinke, C. Ugur, B. Voss, C. Wendel, A. Wilson, D. Branford, D. Glazier, D. Lehmann, S. Loechner, D. Watts, M. Boehm, E. Etzelmueller, M. Galuska, E. Fioravanti, I. Garzia, E. Gutz, C. Hahn, E. K. Koshurnikov, Y. Yu. Lobanov, F. Heinsius, T. Held, F. Lisowski, E. Lisowski, F. Uhlig, S. Dobbs, G. Alexeev, V. A. Arefiev, G. Bracco, M. Macri, G. Korcyl, W. Krzemien, G. Pontecorvo, V. Rodionov, G. Rosner, B. Seitz, G. Schepers, C. J. Schmidt, G. Shabratova, N. B. Skachkov, H. Deppe, R. Dzhygadlo, H. Liu, Z. Liu, H. Orth, M. Patsyuk, H. Stenzel, U. Thoering, H. Zaunick, D. Ireland, I. Augustin, R. Boehm, I. Keshk, H. Koch, I. Kisel, G. Kozlov, I. Lehmann, D. Nicmorus Marinescu, J. Jaworowski, M. Krawczyk, J. Luehning, U. Lynen, J. Plazek, K. Korcyl, J. Pychy, M. Richter, J. Rieke, C. Rosenbaum, J. S. Lange, Y. Liang, J. Zhao, M. Albrecht, K. Brinkmann, V. Di Pietro, K. Peters, T. Saito, K. Seth, A. Tomaradze, K. Swientek, J. Biernat, L. Schmitt, V. Varentsov, L. V. Malinina, V. Malyshev, M. Al-Turany, A. Belias, M. Ball, R. Beck, M. Caprini, D. Pantea, M. Domagala, G. Filo, M. Krebs, U. Kurilla, M. Kube, P. Mahlberg, M. Kuemmel, S. Leiber, M. Michalek, P. Poznanski, M. Mikirtychyants, P. Musiol, M. Pugach, M. Zyzak, M. Rossbach, C. Schmidt, M. Savrie, V. Akishina, M. Schmidt, R. Schnell, M. Suleimanov, R. Teshev, M. Ullrich, M. N. Wagner, M. Urban, D. Walther, M. Zuehlsdorf, V. Abazov, N. I. Zhuravlev, A. G. Zorin, N. Walford, B. Liu, P. Dalpiaz, A. Drago, P. Drexler, M. Dueren, P. Gianotti, C. Guaraldo, P. Lebiedowicz, K. Pysz, P. N. Deepak, A. Kulkarni, P. Salabura, J. Smyrski, P. Strzempek, A. Wronska, P. Wieczorek, A. Wilms, R. F. Parodi, K. Biguenko, R. Karabowicz, R. Kliemt, R. Schmitz, U. Thoma, S. Diehl, V. Dormenev, S. Nazarenko, R. Novotny, T. Erlen, M. Fink, T. Fiutowski, M. Idzik, T. Holtmann, S. Jasper, T. Quagli, S. Reiter, T. Triffterer, U. Wiedner, T. Wasem, B. Wohlfahrt, T. Xiao, D. Bettoni, V. Astakhov, M. Yu. Barabanov, V. Carassiti, A. Cotta Ramusino, V. I. Lobanov, A. F. Makarov, V. Kh. Dodokhov, A. Efremov, V. Lucherini, A. Bersani, V. Metag, M. Nanova, V. Tokmenin, V. Uzhinsky, W. Kuehn, T. Kuske, W. Schaefer, A. Szczurek, X. Shen, C. Wang, Y. Rogov, R. Salmin   +121 more
core   +3 more sources

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

Molecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute, Madeleine Birgersson, Paolo Ceriani, Margareta Wilhelm, Ourania N Kostopoulou   +4 more
wiley   +1 more source

E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer

Molecular Oncology, EarlyView.
Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov, Shiva Krishna Katkam, Zhefan Wang, Venkateshwar G. Keshamouni   +3 more
wiley   +1 more source

A Benchmark Approach to Finance [PDF]

This paper derives a unified framework for portfolio optimization, derivative pricing, financial modeling and risk measurement. It is based on the natural assumption that investors prefer more or less, in the sense that the higher drift is preferred ...
Eckhard Platen
core  

Transição da contabilidade baseada no custo histórico para o justo valor: suas implicações na transparência dos resultados reportados por instituições bancárias [PDF]

, 2015
A presente dissertação teve como objetivo identificar as implicações da transição da mensuração de ativos do custo histórico para o justo valor nos resultados reportados por bancos nigerianos e portugueses, no período compreendido entre 2000 a 2013.
Elias, Crisódio
core